胃食道逆流症和怀孕:安全治疗的建议
Nayeli Ortiz-Olvera1, Juan P Ochoa-Maya1, Marina A González-Martínez2
1Servicio de Gastroenterología.
概括
在怀孕期间胃食道逆流性疾病 (GERD) 需要谨慎管理. 逐步的治疗始于改变生活方式,然后转向抗酸药,阿尔金酸盐,糖酸盐,H2阻断剂,如果有必要,最后是PPI,优先考虑胎儿安全.
科学领域:
- 胃肠病学 胃肠病学
- 产科 产科 产科 产科 产科
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃食道逆流性疾病 (GERD) 影响高达80%的孕妇.
- 治疗目标包括在不伤害胎儿的情况下缓解症状.
研究的目的:
- 提供关于在怀孕期间安全有效治疗GERD的指导.
- 概述一个逐步的药理方法来管理孕妇的GERD.
主要方法:
- 在MEDLINE,PubMed和Cochrane数据库中的系统文献搜索 (1992-2024年).
- 包括随机对照试验,观察性研究,审查和管理建议.
- 专注于GERD治疗,特别是在怀孕期间.
主要成果:
- 建议采取逐步的治疗方法,从改变生活方式开始.
- 含的抗酸剂或酸盐是第一线药理疗法 (A级).
- 糖酸盐 (C级),组胺-2-受体对抗剂 (B级) 和质子抑制剂 (C级) 是持续或严重症状的后续选择,并注明了特定的FDA类别.
结论:
- 怀孕期间的GERD治疗应逐步进行,并优先考虑胎儿安全.
- 某些药物是禁用或缺乏足够的安全数据在怀孕期间.
- 一种结构化的方法可以确保对患有GERD的孕妇进行适当的治疗.
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
216
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
216
Peptic Ulcer Disease IV: Management
146
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
146
Barrett Esophagus-II: Clinical Manifestations and Management
305
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
305
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
525
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
525
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
599
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
599
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
446
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
446


